Investing.com - Gilead (NASDAQ:GILD) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $1.90 on revenue of $7.00. Analysts polled by Investing.com anticipated EPS of $1.52 on revenue of $6.13B.
Gilead shares are down 3% from the beginning of the year, still down 5.29% from its 52 week high of $74.12 set on December 30, 2021.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar